Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · IEX Real-Time Price · USD
2.750
+0.170 (6.59%)
At close: May 31, 2024, 4:00 PM
2.780
+0.030 (1.09%)
After-hours: May 31, 2024, 7:18 PM EDT
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $105.89 million as of May 31, 2024. Its market cap has increased by 121.07% in one year.
Market Cap
105.89M
Enterprise Value
63.32M
1-Year Change
121.07%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since September 17, 2014, Eledon Pharmaceuticals's market cap has decreased from $493.30M to $105.89M, a decrease of -78.53%. That is a compound annual growth rate of -14.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 105.90M | 6.65% |
May 30, 2024 | 99.30M | 7.47% |
May 29, 2024 | 92.40M | -6.95% |
May 28, 2024 | 99.30M | -8.56% |
May 24, 2024 | 108.60M | -2.43% |
May 23, 2024 | 111.30M | -3.30% |
May 22, 2024 | 115.10M | -3.28% |
May 21, 2024 | 119.00M | -0.92% |
May 20, 2024 | 120.10M | 3.27% |
May 17, 2024 | 116.30M | 7.88% |
May 16, 2024 | 107.80M | 11.71% |
May 15, 2024 | 96.50M | 66.09% |
May 14, 2024 | 58.10M | 7.00% |
May 13, 2024 | 54.30M | -5.24% |
May 10, 2024 | 57.30M | -3.86% |
May 9, 2024 | 59.60M | -1.49% |
May 8, 2024 | 60.50M | 7.84% |
May 7, 2024 | 56.10M | -7.27% |
May 6, 2024 | 60.50M | 1.17% |
May 3, 2024 | 59.80M | 4.73% |
May 2, 2024 | 57.10M | 0.53% |
May 1, 2024 | 56.80M | -4.22% |
Apr 30, 2024 | 59.30M | 0.85% |
Apr 29, 2024 | 58.80M | 15.07% |
Apr 26, 2024 | 51.10M | 2.00% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
So-Young International | 110.53M |
DiaMedica Therapeutics | 110.10M |
PDS Biotechnology | 109.30M |
Omega Therapeutics | 109.21M |
Akoya Biosciences | 106.18M |
BrainsWay | 104.74M |
Clearside Biomedical | 104.62M |
VistaGen Therapeutics | 104.32M |